An initiative to establish a framework capable of supporting global clinical trials by carrying out a corporate split with PPD and establishing a joint venture, leveraging PPD’s network of 86 sites in 46 countries worldwide. The initiative will advance the international expansion of the clinical operations business while maintaining the joint venture’s high operating margin.